Beyond Air

Treatment Solutions for Respiratory Diseases

Health Tech & Life Sciences
Public on NASDAQ on Aug, 2015<br>

Company Overview

Snapshot

Founded in May 2011 by Amir Avniel and Yossef Av-Gay, Beyond Air operates with 51–200 employees. The company has raised $69.54 million across 7 funding rounds from 2 investors. In September 2025, Beyond Air announced the exercise of warrants, generating $3.25 million in gross proceeds.

Business overview

Beyond Air is a health tech and life sciences company focused on developing treatment solutions for respiratory diseases. The company leverages the pulmonary, antimicrobial, anti-inflammatory, and immunomodulatory mechanisms of nitric oxide through its LungFit technology platform. This platform generates nitric oxide on-demand from ambient air and delivers it to patients for various lung conditions. Its LungFit PH system, the first and only FDA-approved system with patented Ionizer technology, enables unlimited, on-demand nitric oxide delivery regardless of dose or flow. Beyond Air serves the healthcare and life sciences sectors, targeting providers, patients, and pharmaceutical markets in the United States and Canada.

Strategic signal

In September 2025, Beyond Air announced the exercise of warrants, generating $3.25 million in gross proceeds. This financial activity indicates continued investor confidence and provides additional capital for the company to advance its nitric oxide-based treatment solutions and expand its market reach.

Company Intelligence Q&A

What was a significant recent financial event for Beyond Air?
In September 2025, Beyond Air announced the exercise of warrants, which generated $3.25 million in gross proceeds for the company.
What strategic collaboration did Beyond Air enter into in September 2023?
In September 2023, Beyond Air and Getz Healthcare entered a strategic collaboration to commercialize the LungFit PH system in the Asia-Pacific Region.
What was the outcome of Beyond Air's at-home pilot study for NTM lung infection in October 2022?
In October 2022, Beyond Air announced positive data from an at-home pilot study in patients with refractory NTM lung infection treated with nitric oxide using the LungFit GO system.
When did Beyond Air go public and on which exchange?
Beyond Air became public on NASDAQ in August 2015.
What was a key development regarding Beyond Air's LungFit PH system in September 2024?
In September 2024, Beyond Air provided its LungFit PH System to the U.S. Naval Hospital Guam for neonatal critical care, in partnership with TrillaMed.

External links